Advertisement
News
Advertisement

Elekta’s New Radiation Oncology Technology to Shape the Future of Cancer Care

Mon, 02/04/2013 - 1:46am
The Associated Press

STOCKLOLM & ATLANTA--(BUSINESS WIRE)--Feb 4, 2013--Regulatory News: At an exclusive event scheduled March 1, 2013, Elekta will reveal a leap forward in radiation oncology and the care of individuals with cancer worldwide.

Founded in 1972, Elekta was the first to bring a completely digital linear accelerator to the market, as well as the first to fully integrate imaging technology in the treatment system. Elekta is a market-leading developer of cancer care and neuroscience solutions, including a world-class portfolio of linear accelerators, dedicated radiosurgery and brachytherapy systems and oncology information and treatment planning software solutions.

“At Elekta, we are united by a passion that drives us to constantly strive toward the development of new cancer care solutions that benefit patients, caregivers and healthcare systems,” says Elekta’s President and CEO Tomas Puusepp. “It is this unrelenting dedication to patients and their healthcare providers that has inspired our efforts to create a truly singular technological solution in radiation oncology.”

The worldwide unveiling event will be held Friday, March 1 at the Renaissance Atlanta Waverly Hotel, Atlanta, Georgia, USA, from 11:00-12:00 EST (17:00-18:00 CET).

To attend or view live online, register at www.elekta.com/revealed.

Product availability will be subject to local regulatory clearance.

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide.

For more information, visit http://www.elekta.com

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading